Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Axsome Thera (AXSM)

Axsome Thera (AXSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Axsome Thera One World Trade Center 22nd Floor NEW YORK NY 10007 USA

axsome.com Employees: 545 P: 212-332-3241 F: 212-320-0245

Description:

Axsome Therapeutics is a biopharmaceutical company focused on developing novel therapies for the management of central nervous system (CNS), disorders for which there are limited treatment options available.

Key Statistics

Overview:

Market Capitalization, $K 4,584,506
Enterprise Value, $K 4,376,386
Shares Outstanding, K 48,462
Annual Sales, $ 270,600 K
Annual Net Income, $ -239,240 K
Last Quarter Sales, $ 104,760 K
Last Quarter Net Income, $ -64,600 K
EBIT, $ -299,840 K
EBITDA, $ -290,430 K
60-Month Beta 1.26
% of Insider Shareholders 22.40%
% of Institutional Shareholders 81.49%
Float, K 37,607
% Float 77.60%
Short Volume Ratio 0.45

Growth:

1-Year Return 55.96%
3-Year Return 156.23%
5-Year Return 140.28%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth -132.17%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.34 on 11/12/24
Next Earnings Date N/A
Earnings Per Share ttm -4.40
EPS Growth vs. Prev Qtr -8.06%
EPS Growth vs. Prev Year -1.52%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

AXSM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -158.36%
Return-on-Assets % -37.46%
Profit Margin % -88.41%
Debt/Equity 1.94
Price/Sales 17.10
Price/Cash Flow N/A
Price/Book 47.27
Book Value/Share 1.96
Interest Coverage -35.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar